| Filed On | Filing |
|---|---|
| 15 Oct 2025 |
8-K/A: Departure/Election of Directors or Officers; Compensation
XBiotech Inc. (“XBiotech” or the “Company”) files this Form 8-K/A solely to clarify information regarding director Craig Rademaker’s position at the private equity firm referenced in the first sentence of the third paragraph of the June ... |
| 07 Dec 2016 |
8-K/A: Financial Statements and Exhibits
Corporate Presentation 2016 NASDAQ: XBIT Creating Breakthrough Therapies from Natural Human Immunity |
| 06 Dec 2016 |
8-K/A: Financial Statements and Exhibits
Corporate Presentation 2016 NASDAQ: XBIT Creating Breakthrough Therapies from Natural Human Immunity |
Loading...